Regulated secretion of macrophage migration inhibitory factor is mediated by a non‐classical pathway involving an ABC transporter

The cytokine macrophage migration inhibitory factor (MIF) is inducibly secreted by immune cells and certain other cell types to critically participate in the regulation of the host immune response. However, MIF does not contain a N‐terminal signal sequence and the mechanism of MIF secretion is unknown. Here we show in a model of endotoxin‐stimulated THP‐1 monocytes that MIF does not enter the endoplasmatic reticulum and that MIF secretion is not inhibited by monensin or brefeldin A, demonstrating that MIF secretion occurs via a non‐classical export route. Glyburide and probenicide but not other typical inhibitors of non‐classical protein export strongly block MIF secretion, indicating that the export pathway of MIF involves an ABCA1 transporter.

[1]  L. Leng,et al.  MIF Signal Transduction Initiated by Binding to CD74 , 2003, The Journal of experimental medicine.

[2]  R. Soldi,et al.  S100A13 mediates the copper-dependent stress-induced release of IL-1α from both human U937 and murine NIH 3T3 cells , 2003, Journal of Cell Science.

[3]  R. Bucala,et al.  Purification and Characterization of Macrophage Migration Inhibitory Factor as a Secretory Protein from Rat Epididymis: Evidences for Alternative Release and Transfer to Spermatozoa , 2001, Molecular medicine.

[4]  F. Cozzolino,et al.  A novel secretory pathway for interleukin‐1 beta, a protein lacking a signal sequence. , 1990, The EMBO journal.

[5]  R. Kleemann,et al.  Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. , 1998, Journal of molecular biology.

[6]  R. Bucala,et al.  An Essential Role for Macrophage Migration Inhibitory Factor (MIF) in Angiogenesis and the Growth of a Murine Lymphoma , 1999, Molecular medicine.

[7]  J. Bernhagen,et al.  Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. , 2002, Microbes and infection.

[8]  R. Bucala,et al.  Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.

[9]  R. Bucala,et al.  Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. , 1998, Arthritis and rheumatism.

[10]  G. Palade,et al.  Temperature-sensitive steps in the transport of secretory proteins through the Golgi complex in exocrine pancreatic cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Bernhagen,et al.  Localization of Macrophage Migration Inhibitory Factor (MIF) to Secretory Granules within the Corticotrophic and Thyrotrophic Cells of the Pituitary Gland , 1995, Molecular medicine.

[12]  Frank McCormick,et al.  Brefeldin A The Advantage of Being Uncompetitive , 1999, Cell.

[13]  P. Morgan,et al.  Role of transport proteins in drug absorption, distribution and excretion , 2001, Xenobiotica; the fate of foreign compounds in biological systems.

[14]  R. Atkins,et al.  Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II. , 2003, Kidney international.

[15]  T. Calandra,et al.  Macrophage migration inhibitory factor and innate immune responses to bacterial infections , 2001, Critical care medicine.

[16]  R. Bucala,et al.  Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[17]  S. Tagami,et al.  Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-alpha. , 1997, Biochemical and biophysical research communications.

[18]  Thomas Maciag,et al.  The Extravesicular Domain of Synaptotagmin-1 Is Released with the Latent Fibroblast Growth Factor-1 Homodimer in Response to Heat Shock* , 1998, The Journal of Biological Chemistry.

[19]  A. Galat,et al.  Purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol , 1993, FEBS letters.

[20]  R. Bucala,et al.  Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). , 2000, Seminars in cancer biology.

[21]  R. Sitia,et al.  Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. , 1992, The Journal of biological chemistry.

[22]  R. Bucala,et al.  The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. , 2000, The Journal of clinical investigation.

[23]  R. Bucala,et al.  Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. , 1995, Journal of inflammation.

[24]  J. Bernhagen,et al.  MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.

[25]  K. Tracey,et al.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.

[26]  H. Dockrell.  The Cytokine Handbook , 1993 .

[27]  W. Nickel.  The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. , 2003, European journal of biochemistry.

[28]  J. Bernhagen,et al.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor , 1994, The Journal of experimental medicine.

[29]  J. Bernhagen,et al.  Expression of Macrophage Migration Inhibitory Factor in Different Stages of Human Atherosclerosis , 2002, Circulation.

[30]  S. Aggarwal,et al.  A possible role for multidrug resistance-associated protein in the secretion of basic fibroblast growth factor by osteogenic sarcoma cell line (MG-63). , 1998, International Journal of Oncology.

[31]  J. Bernhagen,et al.  Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). , 1994, Biochemistry.

[32]  T. Kohgo,et al.  Secretion of macrophage migration inhibitory factor differs from interleukin-6 in hydrogen peroxide- and LPS-stimulated human fibroblasts. , 2002, International immunopharmacology.

[33]  R. Bucala,et al.  The Immunoregulatory Mediator Macrophage Migration Inhibitory Factor (MIF) Catalyzes a Tautomerization Reaction , 1996, Molecular medicine.

[34]  M. Torrisi,et al.  The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. , 1999, Molecular biology of the cell.

[35]  Peter Walter,et al.  Protein translocation across the endoplasmic reticulum , 1984, Cell.

[36]  B. Verrier,et al.  ABC1, an ATP Binding Cassette Transporter Required for Phagocytosis of Apoptotic Cells, Generates a Regulated Anion Flux after Expression in Xenopus laevis Oocytes* , 1997, The Journal of Biological Chemistry.

[37]  T. Langmann,et al.  Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice , 2000, Nature Genetics.

[38]  J. Bernhagen,et al.  Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: potential role in cellular redox processes , 1998, FEBS letters.

[39]  A. von Eckardstein,et al.  The ATP binding cassette transporter A1 contributes to the secretion of interleukin 1beta from macrophages but not from monocytes. , 2002, Biochemical and biophysical research communications.

[40]  F. Tarantini,et al.  S100A13 Is Involved in the Regulation of Fibroblast Growth Factor-1 and p40 Synaptotagmin-1 Release in Vitro * , 1998, The Journal of Biological Chemistry.

[41]  A. Vaughan,et al.  ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. , 2000, Current opinion in lipidology.

[42]  R. Soldi,et al.  S100A13 Participates in the Release of Fibroblast Growth Factor 1 in Response to Heat Shock in Vitro * , 2001, The Journal of Biological Chemistry.

[43]  J. Bernhagen,et al.  Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 , 2000, Nature.

[44]  J. Haefliger,et al.  Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Todo,et al.  An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. , 2000, Cytokine.

[46]  F. Tarantini,et al.  The Precursor but Not the Mature Form of IL1α Blocks the Release of FGF1 in Response to Heat Shock* , 2001, The Journal of Biological Chemistry.

[47]  D. Volkin,et al.  Partially structured self-associating states of acidic fibroblast growth factor. , 1993, Biochemistry.

[48]  Igor Prudovsky,et al.  Copper Induces the Assembly of a Multiprotein Aggregate Implicated in the Release of Fibroblast Growth Factor 1 in Response to Stress* , 2001, The Journal of Biological Chemistry.

[49]  J. Bernhagen,et al.  Structure activity studies of the cytokine macrophage migration inhibitory factor (MIF) reveal a critical role for its car☐y terminus , 1997 .

[50]  M. Korbonits,et al.  Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei. , 2003, The Journal of endocrinology.

[51]  J. David.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[52]  A Rubartelli,et al.  Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. , 1997, Blood.